Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3and 24R,25-dihydroxyvitamin D3

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Van Der Meijden, Karen ^a   Lips, Paul ^a   Van Driel, Marjolein ^b   Heijboer, Annemieke C ^a   Schulten, Engelbert A J M ^a   Den Heijer, Martin ^a   Bravenboer, Nathalie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 CYP24; CYTOCHROME P450 CYP27B1; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; SECALCIFEROL; UNCLASSIFIED DRUG; BONE DENSITY CONSERVATION AGENT; COLECALCIFEROL; VITAMIN;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; OSTEOBLAST; PROTEIN EXPRESSION; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; BONE DEVELOPMENT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS;

BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; CHOLECALCIFEROL; HUMANS; OSTEOBLASTS; OSTEOGENESIS; VITAMINS;

EID: 84908143950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110283     Document Type: Article

References (29)

1. Lips P, van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25: 585-591.
2. Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87: 1087S-1091S. 87/4/1087S [pii].
3. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92: 4-8. S0079-6107(06)00008-3 [pii];10.1016/j.pbiomolbio.2006.02.016 [doi].
4. St-Arnaud R (2011) CYP24A1: Structure, Function, and Physiological Role. In: Feldman D, Pike JW, Adams JS, editors. Vitamin D (Third edition). San Diego: Academic Press. 43-56.
5. Slominski AT, Kim TK, Li W, Yi AK, Postlethwaite A, et al. (2014) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144PA: 28-39. S0960-0760(13)00205-7 [pii];10.1016/j.jsbmb.2013.10.012 [doi].
6. 3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J 26: 3901-3915. fj.12-208975 [pii];10.1096/fj.12-208975 [doi].
7. 2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Mol Cell Endocrinol 383: 181-192. S0303-7207(13)00527-3 [pii];10.1016/j.mce.2013.12.012 [doi].
8. Slominski AT, Kim TK, Takeda Y, Janjetovic Z, Brozyna AA, et al. (2014) RORα and RORγ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J 28: 2775-2789. fj.13-242040 [pii];10.1096/fj.13-242040 [doi].
9. van Driel M, Pols HA, van Leeuwen JP (2004) Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 10: 2535-2555.
10. 3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 119: 1776-1785.
11. 3 on the activity and growth of human primary osteoblast-like cells in vitro. Fertil Steril 77: 1038-1043.
12. van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, et al. (2006) Evidence for auto/paracrine actions of vitamin D in bone: 1α-hydroxylase expression and activity in human bone cells. FASEB J 20: 2417-2419.
13. 3. Bone 40: 1517-1528.
14. 3. J Biol Chem 256: 7738-7740.
15. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138: 3864-3872. 10.1210/endo.138.9.5398 [doi].
16. St-Arnaud R (2010) CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol 121: 254-256. S0960-0760(10)00044-0 [pii];10.1016/j.jsbmb.2010.02.002 [doi].
17. 3 enhance human osteoblast differentiation and mineralization. J Cell Biochem 99: 922-935.
18. Beresford JN, Gallagher JA, Gowen M, McGuire MKB, Poser JW, et al. (1983) Human bone cells in culture: a novel system for the investigation of bone cell metabolism. Clinical Sciences 64: 33-39.
19. Marie PJ, Lomri A, Sabbagh A, Basle M (1989) Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol 25: 373-380.
20. 3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase. J Bone Miner Res 26: 1145-1153.
21. 3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J Steroid Biochem Mol Biol 103: 601-605.
22. 3 promotes the osteoblastic differentiation of human mesenchymal stem cells. Mol Endocrinol 28: 644-658. 10.1210/me.2013-1241 [doi].
23. 3 in cultured human osteoblastic cells. Exp Cell Res 244: 71-76. S0014-4827(98)94189-1 [pii]; 10.1006/excr.1998.4189 [doi].
24. Bouillon R, Okamura WH, Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16: 200-257. 10.1210/edrv-16-2-200 [doi].
25. Rowling MJ, Gliniak C, Welsh J, Fleet JC (2007) High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 137: 2608-2615. 137/12/2608 [pii].
26. 3 is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118: 162-170. S0960-0760(09)00282-9 [pii]; 10.1016/j.jsbmb.2009.11.011 [doi].
27. Anderson PH, Atkins GJ (2008) The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29: 397-406.
28. Morris HA (2014) Vitamin D activities for health outcomes. Ann Lab Med 34: 181-186. 10.3343/alm.2014.34.3.181 [doi].
29. Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35: 290-304. ECI1487 [pii]; 10.1111/j.1365-2362.2005.01487.x [doi].